2006, 2004, Icelandic, Article edition: Kostnaðarhagkvæmnisgreining á bólusetningu gegn meningókokkum C á Íslandi; Cost-effectiveness analysis on meningococcal serogroup C vaccination Guðmundur I. Bergþórsson; Þórólfur Matthíasson; Þórólfur Guðnason; ...

User activity

Send to:
 
Bookmark: http://trove.nla.gov.au/version/6460376
Physical Description
  • YES
  • Article
Published
  • Læknafélag Íslands, Læknafélag Reykjavíkur
  • 2006-04-28T14:59:13Z
  • 2004-05-01T14:59:13Z
Language
  • Icelandic

Edition details

Title
  • Kostnaðarhagkvæmnisgreining á bólusetningu gegn meningókokkum C á Íslandi; Cost-effectiveness analysis on meningococcal serogroup C vaccination
Author
  • Guðmundur I. Bergþórsson
  • Þórólfur Matthíasson
  • Þórólfur Guðnason
  • Haraldur Briem
Published
  • Læknafélag Íslands, Læknafélag Reykjavíkur
  • 2006-04-28T14:59:13Z
  • 2004-05-01T14:59:13Z
Physical Description
  • YES
  • Article
Subjects
Notes
  • Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/​Open
  • Meningococci C are bacteria that can cause meningitis and severe bacteremia. In Iceland 8-15 cases of meningococcal disease can be expected annually. The case fatality ratio is approximately 10%. After the approval of the Icelandic government The State Epidemiologist started a vaccination campaign for all individuals from 6 months to 19 years of age in the country. The purpose of this investigation is to evaluate the cost effectiveness of the vaccination programme. The cost effectiveness is made from the viewpoint of the Icelandic state. The cost per year saved is used as a marker for success. The cost effectiveness analysis reveals that the cost per case avoided is 618.000 Icelandic kronas and the cost per life year saved is 101.000 Icelandic kronas. In comparison the cost per case avoided is 2.481.334 Icelandic kronas and the cost per life saved is 857.483 Icelandic kronas in England and Wales.We conclude that vaccination against meningococci C is very cost effective but lower cost in Iceland can mainly be explained by lower cost of distributing and administering the vaccine to the vaccinees in Iceland compared to England and Wales.
  • http:/​/​www.laeknabladid.is
  • Læknablaðið 2004;90(5):379-83
  • 0023-7213
  • 16819032
Language
  • Icelandic
Contributed by
OAIster

Get this edition

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment